Jump to:
Graft Polymer (Uk) PLC Fundamentals
| Company Name | Graft Polymer (Uk) PLC | Last Updated | 2024-05-14 |
|---|
| Industry | Specialty Industrial Machinery | Sector | Industrials |
|---|
| Shares in Issue | 124.764 m | Market Cap | £180,907.75 |
|---|
| PE Ratio | 0.00 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -£0.03 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0.0113 | Debt Equity Ratio | 0.0084 |
|---|
| Asset Equity Ratio | 1.0690 | Cash Equity Ratio | 0.1506 |
|---|
| Quick Ratio | 2.9810 | Current Ratio | 3.68 |
|---|
| Price To Book Value | 0.0893 | ROCE | 0 |
|---|
Graft Polymer (Uk) PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Graft Polymer (Uk) PLC Company Financials
| Assets | 2022 | 2021 |
|---|
| Tangible Assets | £701,000.00 | £364,000.00 |
| Intangible Assets | £2.07 m | £2.07 m |
| Investments | 0 | 0 |
| Total Fixed Assets | £2.78 m | £2.44 m |
| Stocks | £187,000.00 | 0 |
| Debtors | £43,000.00 | £53,000.00 |
| Cash & Equivalents | £1.64 m | £39,000.00 |
| Other Assets | 0 | 0 |
| Total Assets | £4.94 m | £2.57 m |
| Liabilities | 2022 | 2021 |
|---|
| Creditors within 1 year | £367,000.00 | £1.32 m |
| Creditors after 1 year | £18,000.00 | 0 |
| Other Liabilities | 0 | 0 |
| Total Liabilities | £385,000.00 | £1.32 m |
| Net assets | £4.55 m | £1.25 m |
| Equity | 2022 | 2021 |
|---|
| Called up share capital | £41,000.00 | £7,000.00 |
| Share Premium | £9.50 m | £3.44 m |
| Profit / Loss | -£2.71 m | 0 |
| Other Equity | £4.55 m | £1.25 m |
| Preference & Minorities | 0 | 0 |
| Total Capital Employed | £4.55 m | £1.25 m |
| Ratios | 2022 | 2021 |
|---|
| Debt Ratio | £0.00 | 0 |
| Debt-to-Equity | £0.00 | 0 |
| Assets / Equity | 1.0690 | 1.0690 |
| Cash / Equity | 0.1506 | 0.1506 |
| EPS | -£0.03 | 0 |
| Cash Flow | 2022 | 2021 |
|---|
| Cash from operating activities | -£2.36 m | 0 |
| Cashflow before financing | £1.77 m | 0 |
| Increase in Cash | £1.06 m | 0 |
| Income | 2022 | 2021 |
|---|
| Turnover | £542,000.00 | 0 |
| Cost of sales | £242,000.00 | 0 |
| Gross Profit | £300,000.00 | 0 |
| Operating Profit | -£2.70 m | 0 |
| Pre-Tax profit | -£2.71 m | 0 |
Graft Polymer (Uk) PLC Company Background
| Sector | Industrials |
|---|
| Activities | Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. |
|---|
| Latest Interim Date | 27 Sep 2023 |
|---|
| Latest Fiscal Year End Date | 30 Apr 2024 |
|---|
Graft Polymer (Uk) PLC Directors
| Appointed | Name | Position |
|---|
| 2024-01-08 | Mr. Roby Zomer | Non-Executive Director,Chairman |
| 2024-01-08 | Mr. Victor Bolduev | Executive Director,Chief Executive Officer and Chief Technical Officer |
| 2024-01-08 | Ms. Yifat Steuer | Executive Director,Chief Financial Officer |
| 2024-01-08 | Mr. Pavel Kobzev | Executive Director,Chief Marketing Officer |
| 2024-01-08 | Mr. Alexander Samuel Brooks | Non-Executive Director |
Graft Polymer (Uk) PLC Contact Details
Graft Polymer (Uk) PLC Advisors
